Boston Scientific $4.3 billion notes offering

25/2/2019

Investment grade bond/note issue

Value:

$ 4.3 billion

Status:

Completed

Date:

25/2/2019

Overview:

Medical technology company Boston Scientific has made a $4.3 billion notes offering.
The offering consisted of $850 million of 3.45% notes, $850 million of 3.75% notes, $850 million of 4% notes, $750 million of 4.55% notes and $1 billion of 4.7% notes.
The underwriters were led by Barclays Capital, Merrill Lynch Pierce Fenner & Smith and Wells Fargo Securities.

Kurt Stumpo - US Editor

Jurisdiction:

United States

Deal type:

Investment grade bond/note issue

Practice area:

Capital markets : Debt

Governing law:

United States

Industry sectors:

Healthcare
Technology and telecommunications

Firm:

Simpson Thacher & Bartlett

Party: Barclays Capital (Underwriter)

Party: Merrill Lynch Pierce Fenner & Smith (Underwriter)

Party: Wells Fargo Securities (Underwriter)

Lawyer: Roxane Reardon

Related deals